Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
EMR
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
-19%
1.05
vs 1.29
Q2.23
-7%
1.29
vs 1.38
Q3.23
-16%
1.29
vs 1.53
Q4.23
+56%
1.22
vs 0.78
Q1.24
+30%
1.36
vs 1.05
Q2.24
+11%
1.43
vs 1.29
Q3.24
+15%
1.48
vs 1.29
Q4.24
+13%
1.38
vs 1.22
Q1.25
+4%
1.41
vs 1.36
Q2.25
+7%
1.54
vs 1.43
Sales Growth
YoY
Current
Estimates
Q1.23
-22%
3.8B vs 4.8B
Q2.23
-21%
3.9B vs 5B
Q3.23
-24%
4.1B vs 5.4B
Q4.23
+22%
4.1B vs 3.4B
Q1.24
+17%
4.4B vs 3.8B
Q2.24
+11%
4.4B vs 3.9B
Q3.24
+13%
4.6B vs 4.1B
Q4.24
+1%
4.2B vs 4.1B
Q1.25
+0%
4.4B vs 4.4B
Q2.25
+4%
4.5B vs 4.4B
Return on Equity
QoQ
Q1.23
+7%
0.07
vs 0.22
Q2.23
+46%
0.46
vs 0.07
Q3.23
+4%
0.04
vs 0.46
Q4.23
+1%
0.01
vs 0.04
Q1.24
+2%
0.02
vs 0.01
Q2.24
+2%
0.02
vs 0.02
Q3.24
+5%
0.05
vs 0.02
Q4.24
+2%
0.02
vs 0.05
Institutionnal Ownership
QoQ
Q1.23
1799
1.8K
vs 1.8K
-2%
Q2.23
1831
1.8K
vs 1.8K
2%
Q3.23
1848
1.8K
vs 1.8K
1%
Q4.23
1918
1.9K
vs 1.8K
4%
Q1.24
2012
2K
vs 1.9K
5%
Q2.24
1994
2K
vs 2K
-1%
Q3.24
1990
2K
vs 2K
0%
Q4.24
2143
2.1K
vs 2K
8%
seekingalpha.com
7 hours ago
https://www.prnewswire.com
10 hours ago
zacks.com
10 hours ago
zacks.com
12 hours ago
zacks.com
18 hours ago
zacks.com
19 hours ago
Quote Panel
Key Metrics
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
110.00(4.48%)
Number of analyst
1
Last analyst upgrade/downgrade
Barclays
downgradePrevious: Equal-Weight
2025-03-10
Now: Underweight
Stephens
downgradePrevious: Not converted
2024-10-16
Now: Equal-Weight
Morgan Stanley
initialisePrevious: Overweight
2024-09-06
Now: Underweight
Deutsche Bank
upgradePrevious: Buy
2024-05-08
Now: Positive
Relative Strength
EMR
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|